Trump Orders Expansion of Psychedelic Drug Trials — Joe Rogan Attends Signing Ceremony (VIDEO) | The Gateway Pundit | by Ben Kew


Trump Orders Expansion of Psychedelic Drug Trials — Joe Rogan Attends Signing Ceremony (VIDEO)

by
Former President Donald Trump speaking at a desk in the Oval Office, surrounded by advisors and flags, during a formal event.
Screenshot

President Donald Trump has signed an executive order expanding federal research into psychedelic drugs and explore their use in controlled medical settings.

The order direct the Food and Drug Administration to issue new guidance for clinical trials involving substances such as psilocybin, ibogaine, LSD, and MDMA.

The podcast host Joe Rogan, who has long advocated for research into psychedelics, attended the signing ceremony.

Such drugs are currently classified as Schedule I, meaning they are considered to have no accepted medical use and a high potential for abuse.

The administration believes in the potential role of these treatments in addressing post-traumatic stress disorder and other mental health conditions, particularly among military veterans.

The National Institutes of Health is also being tasked with supporting additional studies into the drugs.

Health Secretary Robert F. Kennedy Jr. long advocated for expanding research into psychedelics, arguing they could play a role in treating depression and other conditions.

Ibogaine, one of the substances under consideration, has been linked to potential heart risks.

Former Texas Governor Rick Perry has previously claimed the effects of ibogaine treatment had fantastic potential in treating a variety of health issues.

Researchers and industry figures say restrictions have stunted progress in studying potential medical applications and breakthrough treatments.

However, some experts have warned that widespread use remains years away and would require extensive clinical validation.

Psychedelics such as psilocybin, LSD, and MDMA still remain illegal under federal law and are restricted to approved research.

Some states have begun loosening restrictions, with Oregon and Colorado allowing supervised psilocybin use and New Mexico moving toward a medical program.

Photo of author

Ben Kew
Ben Kew is a writer and editor. Originally from the UK, he moved to the U.S. to cover Congress for Breitbart News and has since gone on to editorial roles at Human Events, Townhall Media, and Americano Media. He has also written for The Epoch Times, The Western Journal, and The Spectator.

You can email Ben Kew here, and read more of Ben Kew’s articles here.

Ad block users: Some site features may not work correctly while an ad blocker is enabled, because they break scripts and content this website depends on. If you can’t see comments below, for example, please disable your ad blocker.

 

Facebook
Twitter
LinkedIn
Telegram
Tumblr